- Alzheimer's disease and related dementias increase costs of comorbidities in managed MedicareJ W Hill
Institute for the Study of Aging, New York, NY 10153, USA
Neurology 58:62-70. 2002..To analyze the relationship between comorbid conditions and costs for patients with AD and related dementias (ADRD) in a Medicare managed care organization (MCO). To derive implications for improving management of patients with ADRD...
- The effect of donepezil therapy on health costs in a Medicare managed care planJerrold W Hill
Institute for the Study for Aging, New York City, USA
Manag Care Interface 15:63-70. 2002..By improving cognitive and daily functioning, donepezil may lower costs by improving medical management...
- Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapyHoward Fillit
Institute for the Study of Aging, New York, USA
Fam Med 34:528-35. 2002..This study analyzed the relationship between co-morbid conditions and health care utilization and costs for patients with AD and estimated costs by stage of disease and receipt of pharmacotherapy...